Hubungan Kadar Resistin dengan C-Reactive Protein dan Prokalsitonin pada Anak dengan Sepsis
Sari
Latar belakang. Sepsis merupakan penyebab utama morbiditas dan mortalitas pada layanan kesehatan anak di seluruh dunia. Resistin merupakan salah satu hormon peptida yang berpotensi sebagai penanda dalam sepsis didasari dari aktivitas resistin dalam sekresi mediator inflamasi.
Tujuan. Penelitian ini bertujuan menilai korelasi kadar resistin dengan CRP dan PCT pada anak yang terdiagnosis sepsis.
Metode. Penelitian cross-sectional dilakukan pada pasien anak berusia usia >1 bulan – 18 tahun yang dirawat di RSHS periode September – Desember 2021. Data yang diambil berupa karakteristik dasar, kadar resistin, CRP, dan PCT. Analisis statistik dilakukan dengan menggunakan uji korelasi Rank Spearman dan analisis multivariat regresi linier.
Hasil. Sebanyak 60 pasien yang terdiri atas 31 (51,7%) perempuan dan 29 (48,3%) laki-laki. Sebagian besar usia berada pada rentang 1-6 tahun (53,3%), dengan median usia sebesar 5,5 tahun dengan IQR sebesar 8,9 tahun. Status gizi pada riset ini sebagian besar normal sebanyak 25 anak (41,7%) dan malnutrisi berat sebanyak 15 (25,0%). Hasil analisis bivariat terdapat korelasi positif lemah antara resistin dengan CRP (r=0,225; p=0,042), tidak terdapat korelasi resitin dengan PCT (r=0,114; p=0,193), serta terdapat korelasi positif sedang antara CRP dengan PCT (r=0,442; p<0,001).
Kesimpulan. Penggunaan resistin sebagai penanda sepsis pada anak-anak harus dikonfirmasi lebih lanjut dengan penelitian lain.
Kata Kunci
Teks Lengkap:
PDFReferensi
Deutschman Clifford S, Tracey Kevin J. Sepsis: Current dogma and new perspectives. Immunity 2014;40:463-75.
Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: A systematic review. Lancet Respir Med 2018;6:223-30.
Hadinegoro SRS, Chairulfatah A, Pudjiadi AH, Malisie RF, Alam A. Konsensus diagnosis dan tata laksana sepsis pada anak. Jakarta: Badan Penerbit Ikatan Dokter Anak Indonesia;2016.h.1-27
Devina T, Lubis M, Mutiara E, dkk. Red cell distribution width and mortality in pediatric sepsis. Paediatr Indones 2016;56:320-4.
Kementerian Kesehatan Republik Indonesia. Pedoman nasional pelayanan kedokteran Ikatan Dokter Anak Indonesia: Diagnosis dan tatalaksana sepsis pada anak. Jakarta: Badan Penerbit Ikatan Dokter Anak Indonesia, 2019.h.55
Kim M-H, Choi J-H. An update on sepsis biomarkers. J Infect Chemother 2020;52:1.
Hung SK, Lan HM, Han ST, Wu CC, Chen KF. Current evidence and limitation of biomarkers for detecting sepsis and systemic infection. Biomedicines 2020;8:494.
Miller L, Singbartl K, Chroneos ZC, Ruiz-Velasco V, Lang CH, Bonavia A. Resistin directly inhibits bacterial killing in neutrophils. Intensive Care Med Exp 2019;7:1-12.
Park HK, Kwak MK, Kim HJ, Ahima RS. Linking resistin, inflammation, and cardiometabolic diseases. Korean J Intern Med 2017;32:239-47.
Khattab AA, El-Mekkawy MS, Helwa MA, Omar ES. Utility of serum resistin in the diagnosis of neonatal sepsis and prediction of disease severity in term and late preterm infants. J Perinat Med 2018;46:919-25.
Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005;6:2-8.
Acquarone E, Monacelli F, Borghi R, Nencioni A, Odetti P. Resistin: A reappraisal. Mech Ageing Dev 2019;178:46-63.
Devanoorkar A, Kathariya R, Guttiganur N, Gopalakrishnan D, Bagchi P. Resistin: A potential biomarker for periodontitis influenced diabetes mellitus and diabetes induced periodontitis. Dis Markers 2014;2014:930206.
Dalamaga M. Resistin as a biomarker linking obesity and inflammation to cancer: Potential clinical perspectives. Biomark Med 2014;8:107-18.
Filková M, Haluzík M, Gay S, Šenolt L. The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol 2009;133:157-70.
Saboktakin L, Bilan N, Behbahan AG, Poorebrahim S. Relationship between resistin levels and sepsis among children under 12 years of age: A case control study. Front Pediatr 2019;7:1-7.
Cekmez F, Canpolat FE, etinkaya M, dkk. Diagnostic value of resistin and visfatin, in comparison with C-reactive protein, procalcitonin and interleukin-6 in neonatal sepsis. Eur Cytokine Netw 2011;22:113-7.
Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients Crit Care 2009;13:1-9.
Pine GM, Batugedara HM, Nair MG. Here, there and everywhere: Resistin-like molecules in infection, inflammation, and metabolic disorders. Cytokine 2018;110:442-51.
Faix JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci 2013;50:23-36.
Lanziotti VS, Póvoa P, Soares M, e Silva JRL, Barbosa AP, Salluh JIF. Use of biomarkers in pediatric sepsis: Literature review. Rev Bras Ter Intensiva 2016;28:472.
Markic J, Saraga M, Dahlem P. Sepsis biomarkers in neonates and children: C-reactive protein and procalcitonin. J Child Sci 2017;7:e89-95.
Pierrakos C, Vincent JL. Sepsis biomarkers: A review. Crit Care 2010;14:1-18.
Standage SW, Wong HR. Biomarkers for pediatric sepsis and septic shock. Expert Rev Anti Infect Ther 2011;9:71-9.
Lausten-Thomsen U, Christiansen M, Hedley PL, dkk. Reference values for fasting serum resistin in healthy children and adolescents. Clin Chim Acta 2017;469:161-5.
Takemoto K, Deckelbaum RJ, Saito I, Likitmaskul S, Morandi A, Pinelli L. Adiponectin/resistin levels and insulin resistance in children: A four country comparison study. Int J Pediatr Endocrinol 2015;2015:2:1-12.
Heilbronn LK, Rood J, Janderova L, Albu JB, Kelley DE, Ravussin E. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 2004;89:1844-8.
Jamurtas AZ, Stavropoulos-Kalinoglou A, Koutsias S, Koutedakis Y, Fatouros I. Adiponectin, resistin, and visfatin in childhood obesity and exercise. Pediatr Exerc Sci 2015;27:454-62.
Gerber M, Boettner A, Seidel B, dkk. Serum resistin levels of obese and lean children and adolescents: Biochemical analysis and clinical relevance. J Clin Endocrinol Metab 2005;90:4503-9.
Savage DB, Sewter CP, Klenk ES, dkk. Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans Diabetes 2001;50:2199-202.
Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 2001;285:561-4.
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-808.
DOI: http://dx.doi.org/10.14238/sp24.3.2022.196-202
Refbacks
- Saat ini tidak ada refbacks.
##submission.copyrightStatement##
##submission.license.cc.by-nc-sa4.footer##
Email: editorial [at] saripediatri.org
Sari Pediatri diterbitkan oleh Badan Penerbit Ikatan Dokter Anak Indonesia
Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.